Transport of Val-Leu-Pro-Val-Pro in Human Intestinal Epithelial (Caco-2) Cell Monolayers

Citations Over Time

Abstract

Angiotensin converting enzyme (ACE) inhibitory peptides are biologically active peptides that play a very important role in blood pressure regulation. In previous experiments, we obtained an ACE inhibitory peptide Val-Leu-Pro-Val-Pro (VLPVP) by DNA recombinant technology. The purpose of this study was to examine the bidirectional transport of VLPVP by using the human intestinal Caco-2 monolayers. The permeability coefficient ( P app) values of VLPVP over 4-8 mmol/L ranged from 7.44 x 10(-8) to 1.35 x 10(-6) cm/s for apical (AP) to basolateral (BL) transport, while the P app values for BL to AP flux were significantly lower than those for the AP to BL flux, with efflux ratio values of 0.74-0.13 over 4-8 mM. Preincubation of the paracellular transport enhancer (sodium deoxycholate), the inhibitor of multidrug resistant protein (MK-571), or sodium azide stimulated efflux of VLPVP significantly ( p < 0.01); these results indicate that the transport of VLPVP across Caco-2 monolayers was involved in paracellular diffusion and MRP2 transport.

Related Papers

• → Expression and function of efflux drug transporters in the intestine(2005)356 cited
• → Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: Comparison between human segments and Caco-2 cells(2006)200 cited
• → Rhamnolipids enhance epithelial permeability in Caco-2 monolayers(2013)43 cited
• → Apple extract induces increased epithelial resistance and claudin 4 expression in Caco‐2 cells(2011)33 cited
• → Sinusoidal efflux of taurocholate correlates with the hepatic expression level of Mrp3(2002)30 cited